Genmab's research and development activities are conducted at our facilities in Utrecht, The Netherlands. These state of the art laboratories are highly automated, allowing us to utilize the transgenic mouse technology in the most optimal way possible. Our cutting edge technology enables us to rapidly choose disease targets, develop large panels of fully human antibodies and choose the best antibodies for clinical development. This Virtual Lab Tour will give you further insight into Genmab's extensive antibody development capabilities.